ENTERA BIO IS-0000769 (5DT) — Financial Flexibility Index
ENTERA BIO IS-0000769 (5DT) has a Financial Flexibility Index of -0.62x as of December 2025. Free cash flow of €-1.81 Million (operating CF €-1.83 Million minus capex €27.00K) represents -1% of total liabilities (€2.89 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ENTERA BIO IS-0000769 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for ENTERA BIO IS-0000769 across 5 annual periods. See ENTERA BIO IS-0000769 (5DT) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ENTERA BIO IS-0000769 (2021–2025)
Year-by-year free cash flow to debt coverage for ENTERA BIO IS-0000769. For the full company profile including market capitalisation, see market value of ENTERA BIO IS-0000769.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.51x | €-7.26 Million | €-7.37 Million | €2.89 Million | ▲ +51.7% |
| 2024 | -5.20x | €-6.82 Million | €-6.82 Million | €1.31 Million | ▲ +1.6% |
| 2023 | -5.29x | €-7.29 Million | €-7.31 Million | €1.38 Million | ▲ +41.7% |
| 2022 | -9.07x | €-12.45 Million | €-12.50 Million | €1.37 Million | ▼ -243.1% |
| 2021 | -2.64x | €-9.05 Million | €-9.06 Million | €3.42 Million | — |